BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23222382)

  • 1. Effects of spleen status on early outcomes after hematopoietic cell transplantation.
    Akpek G; Pasquini MC; Logan B; Agovi MA; Lazarus HM; Marks DI; Bornhaeüser M; Ringdén O; Maziarz RT; Gupta V; Popat U; Maharaj D; Bolwell BJ; Rizzo JD; Ballen KK; Cooke KR; McCarthy PL; Ho VT
    Bone Marrow Transplant; 2013 Jun; 48(6):825-31. PubMed ID: 23222382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.
    Rezvani AR; Storer BE; Guthrie KA; Schoch HG; Maloney DG; Sandmaier BM; Storb R
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):105-12. PubMed ID: 25278458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonfluorodeoxyglucose-Avid Persistent Splenomegaly at Time of Transplantation Delays Neutrophil and Platelets Engraftment without Affecting Survival in Patients with Lymphomas Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Khimani F; Jeong DK; Miladinovic B; Nishihori T; Ayala E; Locke F; Mishra A; Chavez J; Shah B; Gage K; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2201-2207. PubMed ID: 27660169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34
    Scordo M; Bhatt V; Hilden P; Smith M; Thoren K; Cho C; Shah GL; Maloy MA; Papadopoulos EB; Jakubowski AA; Avecilla ST; O'Reilly RJ; Castro-Malaspina H; Tamari R; Shaffer BC; Boelens JJ; Perales MA; Giralt SA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1526-1535. PubMed ID: 30831208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
    Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
    Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
    Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
    Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
    Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
    Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).
    Polverelli N; Mauff K; Kröger N; Robin M; Beelen D; Beauvais D; Chevallier P; Mohty M; Passweg J; Rubio MT; Maertens J; Finke J; Bornhäuser M; Vrhovac R; Helbig G; Mear JB; Castagna L; Reményi P; Angelucci E; Karakasis D; Rifòn J; Sirait T; Russo D; de Wreede L; Czerw T; Hernández-Boluda JC; Hayden P; McLornan D; Yakoub-Agha I
    Am J Hematol; 2021 Jan; 96(1):69-79. PubMed ID: 33064301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Remberger M; Törlén J; Ringdén O; Engström M; Watz E; Uhlin M; Mattsson J
    Biol Blood Marrow Transplant; 2015 May; 21(5):889-93. PubMed ID: 25662230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
    O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ
    Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Omer AK; Weisdorf DJ; Lazaryan A; Shanley R; Blazar BR; MacMillan ML; Brunstein C; Bejanyan N; Arora M
    Biol Blood Marrow Transplant; 2016 May; 22(5):879-83. PubMed ID: 26743342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies.
    Moneib H; Hafez H; Abdalla A; Hassanain O; Lehmann L; Haddad AE
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e221-e227. PubMed ID: 30846344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation.
    Zaucha JM; Gooley T; Bensinger WI; Heimfeld S; Chauncey TR; Zaucha R; Martin PJ; Flowers ME; Storek J; Georges G; Storb R; Torok-Storb B
    Blood; 2001 Dec; 98(12):3221-7. PubMed ID: 11719357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
    Maziarz RT; Devos T; Bachier CR; Goldstein SC; Leis JF; Devine SM; Meyers G; Gajewski JL; Maertens J; Deans RJ; Van't Hof W; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):720-8. PubMed ID: 25555450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.
    Han TT; Xu LP; Liu DH; Liu KY; Wang FR; Wang Y; Yan CH; Chen YH; Sun YQ; Ji Y; Wang JZ; Zhang XH; Huang XJ
    Ann Hematol; 2015 Jan; 94(1):117-28. PubMed ID: 25069650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation.
    Pichler H; Witt V; Winter E; Boztug H; Glogova E; Pötschger U; Matthes-Martin S; Fritsch G
    Biol Blood Marrow Transplant; 2014 May; 20(5):676-83. PubMed ID: 24492145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.